NCT00664937View on ClinicalTrials.gov

Exercise Induced Bronchoconstriction (0476-359)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Asthma, Exercise-induced
Interventions
DRUG

montelukast sodium

single oral dose, before exercise challenge, of montelukast 10mg; 7 week duration.

DRUG

Comparator: placebo (unspecified)

single oral dose, before exercise challenge, of Pbo; 7 week duration.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00664937 - Exercise Induced Bronchoconstriction (0476-359) | Biotech Hunter | Biotech Hunter